share_log

HC Wainwright & Co. Downgrades IGM Biosciences to Neutral, Lowers Price Target to $7

HC Wainwright & Co. Downgrades IGM Biosciences to Neutral, Lowers Price Target to $7

HC Wainwright & Co.将IGM Biosciences的评级下调至中性,将目标股价下调至7美元
Benzinga ·  2023/12/07 11:10

HC Wainwright & Co. analyst Robert Burns downgrades IGM Biosciences (NASDAQ:IGMS) from Buy to Neutral and lowers the price target from $11 to $7.

HC Wainwright & Co. 分析师罗伯特·伯恩斯将IGM Biosciences(纳斯达克股票代码:IGMS)的评级从买入下调至中性,并将目标股价从11美元下调至7美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发